EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹35.96 | ₹27.50 | ₹29.42 | ₹36.62 | ₹21.68 |
What is the latest Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹35.96 |
| Mar2024 | ₹27.50 |
| Mar2023 | ₹29.42 |
| Mar2022 | ₹36.62 |
| Mar2021 | ₹21.68 |
How is Earnings Per Share (EPS) of EMCURE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹35.96 | 30.76 | |
| Mar2024 | ₹27.50 | -6.53 | |
| Mar2023 | ₹29.42 | -19.66 | |
| Mar2022 | ₹36.62 | 68.91 | |
| Mar2021 | ₹21.68 | - | |
Compare Earnings Per Share (EPS) of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹30,121.8 Cr | 3.2% | 9.3% | 58.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.2% |
9.3% |
58.6% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses